Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer’s disease (review of Technology Appraisal No. 111): a systematic review and economic model.
PaperCitations, authors & open-access status
The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer’s disease (review of Technology Appraisal No. 111): a systematic review and economic model. is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 307 citations, 2012 year and diamond oa status.
307
Citations
2012
Year
diamond
OA Status